CD4 and cervical carcinoma: To this end, we cultured an HPV-negative human cervical cancer cell line [i.e., C33A; (37)] with the media from primary CD4+ T-cells infected with a replication-competent HIV-1 NL4-3 strain versus uninfected controls (Figure S1).